Additional 45,000 Paxlovid Doses to Be Procured Tomorrow

Paxlovid Stock for 67,000 People
Lagevrio Stock for 99,000 People Remaining

[Image source=Yonhap News]

[Asia Economy Reporter Ki Ha-young] An additional 45,000 doses of the oral COVID-19 treatment Paxlovid will arrive in South Korea on the 31st.

The Central Disease Control Headquarters announced on the 30th that out of the 962,000 doses of Paxlovid purchased through a contract with Pfizer, 45,000 doses will be additionally imported on the 31st. Initially, the contract quantity for Paxlovid was 762,000 doses, but the government purchased an additional 200,000 doses on the 28th.

Since the initial shipment of 21,000 doses arrived on January 13, a total of 207,000 doses of Paxlovid have been imported into the country. Including the shipment arriving on the 31st, a total of 252,000 doses will have been delivered.

According to the Disease Control Headquarters, as of the 29th, a total of 140,000 doses of Paxlovid have been used, leaving a remaining stock of 67,000 doses.

Another oral treatment, Lagevrio from Merck & Company (MSD), has had a total of 100,000 doses imported. Lagevrio was prescribed to 1,000 confirmed patients over four days starting from the 26th, leaving a total of 99,000 doses remaining.

This content was produced with the assistance of AI translation services.